1.
Product Overview
2.
Research Methodology
3.
Executive Summary
4.
Impact of COVID-19 on Global
Artificial Insemination Market
5.
Voice of Customer
6.
Global Artificial Insemination
Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value
6.2.
Market Share & Forecast
6.2.1. By Technique (Intrauterine, Intracervical, Intravaginal, Intratubal)
6.2.2. By Component (Insemination Kits, Home Conception Devices, Others)
6.2.3. By Source (AIH-Husband v/s AID-Donor)
6.2.4. By End User (Hospitals, Fertility Clinics & Centers, Others)
6.2.5. By Company (2021)
6.2.6.
By Region
6.3.
Product Market Map
7.
North America Artificial
Insemination Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Technique
7.2.2. By Component
7.2.3. By Source
7.2.4. By End User
7.2.5. By Country
7.3.
North America: Country Analysis
7.3.1. United States Artificial Insemination Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Technique
7.3.1.2.2.
By Component
7.3.1.2.3.
By Source
7.3.1.2.4.
By End User
7.3.2. Mexico Artificial Insemination Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Technique
7.3.2.2.2.
By Component
7.3.2.2.3.
By Source
7.3.2.2.4.
By End User
7.3.3. Canada Artificial Insemination Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Technique
7.3.3.2.2.
By Component
7.3.3.2.3.
By Source
7.3.3.2.4.
By End User
8.
Europe Artificial Insemination
Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Technique
8.2.2. By Component
8.2.3. By Source
8.2.4. By End User
8.2.5. By Country
8.3.
Europe: Country Analysis
8.3.1. France Artificial Insemination Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Technique
8.3.1.2.2.
By Component
8.3.1.2.3.
By Source
8.3.1.2.4.
By End User
8.3.2. Germany Artificial Insemination Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Technique
8.3.2.2.2.
By Component
8.3.2.2.3.
By Source
8.3.2.2.4.
By End User
8.3.3. United Kingdom Artificial Insemination Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Technique
8.3.3.2.2.
By Component
8.3.3.2.3.
By Source
8.3.3.2.4.
By End User
8.3.4. Italy Artificial Insemination Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Technique
8.3.4.2.2.
By Component
8.3.4.2.3.
By Source
8.3.4.2.4.
By End User
8.3.5. Spain Artificial Insemination Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Technique
8.3.5.2.2.
By Component
8.3.5.2.3.
By Source
8.3.5.2.4.
By End User
9.
Asia-Pacific Artificial
Insemination Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1. By Technique
9.2.2. By Component
9.2.3. By Source
9.2.4. By End User
9.2.5. By Country
9.3.
Asia-Pacific: Country Analysis
9.3.1. China Artificial Insemination Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Technique
9.3.1.2.2.
By Component
9.3.1.2.3.
By Source
9.3.1.2.4.
By End User
9.3.2. India Artificial Insemination Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Technique
9.3.2.2.2.
By Component
9.3.2.2.3.
By Source
9.3.2.2.4.
By End User
9.3.3. South Korea Artificial Insemination Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Technique
9.3.3.2.2.
By Component
9.3.3.2.3.
By Source
9.3.3.2.4.
By End User
9.3.4. Japan Artificial Insemination Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Technique
9.3.4.2.2.
By Component
9.3.4.2.3.
By Source
9.3.4.2.4.
By End User
9.3.5. Australia Artificial Insemination Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Technique
9.3.5.2.2.
By Component
9.3.5.2.3.
By Source
9.3.5.2.4.
By End User
10.
South America Artificial
Insemination Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Technique
10.2.2. By Component
10.2.3. By Source
10.2.4. By End User
10.2.5. By Country
10.3.
South America: Country Analysis
10.3.1. Brazil Artificial Insemination Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Technique
10.3.1.2.2.
By Component
10.3.1.2.3.
By Source
10.3.1.2.4.
By End User
10.3.2. Argentina Artificial Insemination Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Technique
10.3.2.2.2.
By Component
10.3.2.2.3.
By Source
10.3.2.2.4.
By End User
10.3.3. Colombia Artificial Insemination Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Technique
10.3.3.2.2.
By Component
10.3.3.2.3.
By Source
10.3.3.2.4.
By End User
11.
Middle East and Africa
Artificial Insemination Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value
11.2.
Market Share & Forecast
11.2.1. By Technique
11.2.2. By Component
11.2.3. By Source
11.2.4. By End User
11.2.5. By Country
11.3.
MEA: Country Analysis
11.3.1. South Africa Artificial Insemination Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1.
By Technique
11.3.1.2.2.
By Component
11.3.1.2.3.
By Source
11.3.1.2.4.
By End User
11.3.2. Saudi Arabia Artificial Insemination Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1.
By Technique
11.3.2.2.2.
By Component
11.3.2.2.3.
By Source
11.3.2.2.4.
By End User
11.3.3. UAE Artificial Insemination Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1.
By Technique
11.3.3.2.2.
By Component
11.3.3.2.3.
By Source
11.3.3.2.4.
By End User
11.3.4. Egypt Artificial Insemination Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1.
By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1.
By Technique
11.3.4.2.2.
By Component
11.3.4.2.3.
By Source
11.3.4.2.4.
By End User
11.3.5. Turkey Artificial Insemination Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1.
By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1.
By Technique
11.3.5.2.2.
By Component
11.3.5.2.3.
By Source
11.3.5.2.4.
By End User
12.
Market Dynamics
12.1.
Drivers
12.2.
Challenges
13.
Market Trends &
Developments
14.
Competitive Landscape
14.1.
Rocket Medical plc
14.2.
Kitazato Corporation
14.3.
Vitrolife AB
14.4.
Genea Limited
14.5.
Rinovum Women’s Health, LLC
14.6.
Pride Angel Limited
14.7.
FUJIFILM Irvine Scientific, Inc.
14.8.
Conceivex, Inc.
14.9.
Surelife Pte Ltd.
14.10.
Biogenics Inc.
15. Strategic Recommendations